Primary study · included by 1 review

Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy.

Van der Doelen 2021 · van der Doelen Maarten J, Mehra Niven, van Oort Inge M, et al. · Urologic oncology · 2021

Included by

Non-Cochrane · intervention · 2026 · cited as Van der Doelen 2021 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.